688626.SS SHH
Xiangyu Medical Co.,Ltd
1W: -4.7%
1M: -2.6%
3M: -14.0%
YTD: -38.3%
1Y: -27.0%
3Y: -3.0%
5Y: -48.2%
¥41.95 ($6.26)
-0.10 (-0.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$768M
+3.3% ▲
5Y CAGR: +9.2%
Gross Profit
$768M
+56.4% ▲
5Y CAGR: +18.2%
Operating Income
$77M
-29.0% ▼
5Y CAGR: -19.2%
Net Income
$79M
-23.6% ▼
5Y CAGR: -16.7%
EPS (Diluted)
$0.51
-22.7% ▼
5Y CAGR: -20.8%
EBITDA
$111M
-25.7% ▼
5Y CAGR: -8.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $523M | $489M | $745M | $744M | $768M |
| YoY Growth | +5.6% | -6.7% | +52.5% | -0.2% | +3.3% |
| Cost of Revenue | $170M | $170M | $243M | $253M | $0 |
| Gross Profit | $354M | $318M | $501M | $491M | $768M |
| Gross Margin | 67.6% | 65.2% | 67.3% | 66.0% | 100.0% |
| R&D Expenses | $69M | $92M | $107M | $152M | $0 |
| SG&A Expenses | $140M | $176M | $210M | $274M | $0 |
| Operating Expenses | $130M | $183M | $257M | $382M | $691M |
| Operating Income | $224M | $135M | $245M | $109M | $77M |
| Operating Margin | 42.8% | 27.7% | 32.8% | 14.6% | 10.0% |
| Interest Expense | $62K | $537K | $6M | $6M | $0 |
| Income Before Tax | $223M | $133M | $244M | $107M | $75M |
| Tax Expense | $23M | $10M | $16M | $4M | -$4M |
| Net Income | $202M | $125M | $227M | $103M | $79M |
| Net Margin | 38.6% | 25.7% | 30.5% | 13.8% | 10.3% |
| EPS (Diluted) | $1.35 | $0.79 | $1.44 | $0.66 | $0.51 |
| EBITDA | $154M | $70M | $209M | $105M | $111M |
| Shares Outstanding | 160M | 159M | 158M | 149M | 154M |